Centerspace

CSR remains in a Stage 4 decline with a clear lower‐high/lower‐low sequence. Price is below the declining 9/20 EMAs and 50 DMA, and the recent rally into the EMA zone was rejected, reinforcing medium‐term bearish asymmetry. Short‐term execution favors selling now at the short‐term EMA resistance to capture the next leg down.

• ↑4.8% year-over-year same-store NOI growth drives cash flow
• ↑Completed $493M in asset transactions to optimize portfolio quality
• ↓Earnings yield is deeply negative, reflecting scant return potential